WHO ICTRP trial
Randomized multi-centre open-label non-inferiority phase 3 clinical trial for…
DRKS00021160 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00021160 |
|---|---|
| Public title | Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV childhood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standard arm) with upfront Vincristine, Carboplatin and Etoposide (VCE, experimental arm) |
| Scientific title | Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV childhood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standard arm) with upfront Vincristine, Carboplatin and Etoposide (VCE, experimental arm) - Randomet2017 |
| Primary sponsor | GPOH gGmbH |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Austria;Belgium;Brazil;Switzerland;Czechia;Germany;Denmark;Spain;France;United Kingdom;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Sweden;Vatican City |
| Conditions | Metastatic childhood renal tumour C64;Malignant neoplasm of kidney, except renal pelvis |
| Interventions | Group 1: Preoperative chemotherapy with vincristine, actinomycin D and doxorubicin. - Actinomycin D, 1 x 45 µg/kg IV day 1 in week 1, 3, 5 - Vincristine, 1 x 1,5 mg/m2 IV day 1 in week 1, 2, 3, 4, 5, 6 - Doxorubicin, 1 x 50 mg/m2 6h… |
| Registration date | May 26, 2020 |
| Target size | 406 |
| Secondary IDs | EUCT 2023-508926-91-00;2018-000533-13 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: